Upstream Bio, Inc. UPB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $96.72M+35.6% | $101.58M-68.8% | $72.16M+119% | $45.46M-4.0% | $71.31M+126% | ||
| $197.86M-45.1% | $239.93M+66.0% | $300.26M+60.0% | $348.12M— | $360.07M— | ||
| $194K0.0% | $194K0.0% | $194K0.0% | $194K— | $194K— | ||
| $1.03M+82.7% | $668K+9.0% | $683K+12.5% | $937K— | $566K— | ||
| $20.67M-5.4% | $9.62M+18.8% | $15.91M+165% | $23.75M+1,246% | $21.84M+1,183% | ||
| $316.28M-30.3% | $351.8M-26.6% | $389.02M+71.2% | $418.27M— | $453.79M— | ||
| $510K-5.4% | $559K-4.0% | $616K+6.6% | $544K— | $539K— | ||
| $1.07M-35.1% | $1.22M-31.5% | $1.37M-28.5% | $1.51M— | $1.65M— | ||
| $318.05M-30.3% | $353.77M-26.6% | $391.2M+68.1% | $420.52M— | $456.17M— | ||
| $1.71M-63.8% | $2.73M-32.5% | $3.95M-19.3% | $2.55M-30.6% | $4.72M+867% | ||
| $11.24M+171% | $10.01M+67.0% | $7.24M+36.7% | $7.67M— | $4.14M— | ||
| $724K+2.3% | $720K+2.3% | $716K+5.6% | $712K— | $708K— | ||
| $13.67M+42.9% | $13.45M+25.3% | $11.91M+9.5% | $10.93M— | $9.57M— | ||
| $390K-60.7% | $549K-51.4% | $703K-44.3% | $849K— | $992K— | ||
| —— | $1.27M-30.8% | —— | —— | —— | ||
| $14.06M+33.1% | $14M+18.0% | $12.61M+3.9% | $11.78M— | $10.56M— | ||
| $54K+1.9% | $54K+1.9% | $56K+1,767% | $54K— | $53K— | ||
| $678.66M+2.3% | $673.41M+1.9% | $669.8M+7,449% | $666.45M— | $663.24M— | ||
| -$374.81M-71.9% | -$334.22M-75.2% | -$291.76M-72.1% | -$258.02M— | -$218.05M— | ||
| $100K-72.8% | $530K+2,220% | $493K+40.5% | $258K— | $368K— | ||
| $304M-31.8% | $339.77M-27.7% | $378.58M+336% | $408.74M+379% | $445.61M+434% | ||
| $318.05M-30.3% | $353.77M-26.6% | $391.2M+68.1% | $420.52M— | $456.17M— | ||
| $1.07M-35.1% | $1.22M-31.5% | $1.37M-28.5% | $1.51M— | $1.65M— | ||
| $1.07M-35.1% | $1.22M-31.5% | $1.37M-28.5% | $1.51M— | $1.65M— | ||
| $197.86M-45.1% | $239.93M+66.0% | $300.26M+60.0% | $348.12M— | $360.07M— | ||
| $1.07M-35.1% | $1.22M-31.5% | $1.37M-28.5% | $1.51M— | $1.65M— | ||
| $11.24M+171% | $10.01M+67.0% | $7.24M+36.7% | $7.67M— | $4.14M— | ||
| $1.11M-34.5% | $1.27M-30.8% | $1.42M-26.9% | $1.56M— | $1.7M— | ||
| $54K+1.9% | $54K+1.9% | $56K+1,767% | $54K— | $53K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Upstream Bio, Inc.'s total assets?
- Upstream Bio, Inc. (UPB) holds $318.1M in total assets, down 30.3% year over year.
- How much debt does Upstream Bio, Inc. have?
- Upstream Bio, Inc. carries $1.1M in total debt against $304.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Upstream Bio, Inc. have?
- Upstream Bio, Inc. holds $96.7M in cash and equivalents.
- Can Upstream Bio, Inc. cover its short-term obligations?
- Its current ratio is 23.14 — current assets exceed current liabilities.
- Where does Upstream Bio, Inc.'s balance sheet data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
